LFM
HALO icon

LGT Fund Management’s Halozyme HALO Stock Holding History

LGT Fund Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88,000
Closed -$5.96M – 258
2025
Q4 		$5.96M Buy
+88,000
New +$5.92M 0.47% 46
2025
Q3 		– Sell
-33,600
Closed -$1.75M – 242
2025
Q2 		$1.75M Buy
+33,600
New +$1.91M 0.15% 137

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LGT Fund Management's HALO Position: Q1 2026 in Review

LGT Fund Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 88,000 shares — an estimated $5.96M sold.

LGT Fund Management first reported a position in HALO in Q2 2025 and held it in 2 quarters. The position peaked at $5.96M in Q4 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • LGT Fund Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • LGT Fund Management sold 88,000 Halozyme shares in Q1 2026, an estimated $5.96M.
  • LGT Fund Management first reported a position in Halozyme in Q2 2025 and held it in 2 quarters.
  • LGT Fund Management's Halozyme position peaked at $5.96M in Q4 2025.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on LGT Fund Management's 13F filing for Q1 2026, filed 28 Apr 2026.